Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
about
Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogensProteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancerPrognostic significance of oestrogen receptor beta in breast cancer.Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women.The therapeutic potential of novel aromatase inhibitors in breast cancer.Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.A detailed mammosphere assay protocol for the quantification of breast stem cell activity.Where does radioimmunotherapy fit in the management of breast cancer?Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?Inducible site-directed recombination in mouse embryonic stem cellsRegulation of breast cancer stem cell activity by signaling through the Notch4 receptor.Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer.Essiac and Flor-Essence herbal tonics stimulate the in vitro growth of human breast cancer cells.Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures.Endocrine resistance in advanced breast cancer.Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro.GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat.Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.Fulvestrant: A Review in Advanced Breast Cancer Not Previously Treated with Endocrine Therapy.Estrogen receptors: role in breast cancer.
P2860
Q24796233-C81CFF33-15A8-459A-A273-7C093ABEA822Q33721926-EB54A826-2BF3-46EC-921B-8B2D40AFB704Q33888615-CA5A09C7-F5FD-40C4-8DD9-72A4DD0C329AQ34626963-626786D1-777C-42A2-984A-6BF497475B9BQ36181280-1AFFB7B8-1B0F-465A-8761-54CFCA75B915Q36614435-9255F9A4-0F9E-4613-91ED-91E7C688F8EEQ38016117-46A346CB-F62D-4893-9706-73AD377479D5Q38125535-4FB589B1-1D22-477A-A8B1-CBA6078D17C7Q39095837-62F52590-072C-4B09-826C-254B89C23794Q39715564-8BD815D5-31F5-445C-BF56-BB679A5D29DAQ39752820-0905F089-CA45-49BB-A744-CC309A831A16Q39779772-2E1F3218-5BA5-4C57-AC9B-F6F8E001AAA3Q40303949-C9BA2863-D9ED-4F79-999E-EC17C005B52BQ40985248-04E13D4F-6332-470F-BE1D-5A432FEED145Q41463949-3EEFE45F-E3AF-4002-8EFA-85BE51879275Q42445585-65F756DD-B297-45D1-9D59-23F52468A27BQ46678900-AAB88D41-0336-4322-8109-8A653FBEA510Q47347568-E4AC2150-4B4D-415B-8708-074397CE4165Q52739363-E91117DE-7AE6-4046-8DB3-9C7B1B40EB72Q53595317-4268155C-DD32-48F7-A4CC-F79BD3B0E70F
P2860
Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Effects of 4-hydroxytamoxifen ...... breast cancer cells in vitro.
@ast
Effects of 4-hydroxytamoxifen ...... breast cancer cells in vitro.
@en
type
label
Effects of 4-hydroxytamoxifen ...... breast cancer cells in vitro.
@ast
Effects of 4-hydroxytamoxifen ...... breast cancer cells in vitro.
@en
prefLabel
Effects of 4-hydroxytamoxifen ...... breast cancer cells in vitro.
@ast
Effects of 4-hydroxytamoxifen ...... breast cancer cells in vitro.
@en
P2093
P2860
P356
P1476
Effects of 4-hydroxytamoxifen ...... n breast cancer cells in vitro
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.281
P407
P577
1994-08-01T00:00:00Z